Login
Bruker Corp logo

Bruker Corp

bruker.com

Bruker Corp (NASDAQ: BRKR) is a scientific instruments company that designs, manufactures, and sells analytical and diagnostic systems used in life science, materials research, and semiconductor applications. Revenue comes from instrument sales and associated services, software, and consumables across three reporting segments: BSI BioSpin, BSI CALID, and BSI NANO. BSI BioSpin covers nuclear magnetic resonance and MRI systems, including ultra-high-field NMR platforms at 1 GHz and above. BSI CALID covers mass spectrometry, including the timsTOF platform and MALDI BioTyper systems used in clinical microbiology and diagnostics. BSI NANO covers X-ray, electron microscopy, atomic force microscopy, and related metrology systems, including tools for AI semiconductor chip yield management and High Bandwidth Memory production. Certain products, including the MALDI BioTyper CA system, are regulated as medical devices by the FDA under 510(k) premarket clearance. Bruker transacts with government agencies under contracts where it generally retains at least non-exclusive intellectual property rights. The company is headquartered in Billerica, Massachusetts.

Products & Services

Products include ultra-high-field NMR systems (1 GHz and above), benchtop Fourier NMR platforms, timsTOF mass spectrometers, MALDI BioTyper clinical microbiology systems (FDA 510(k)-cleared and EU IVD-CE certified), X-ray microcomputed tomography systems, EBSD detectors using direct electron detection, transmission electron microscopes, automated uXRD and uXRF X-ray systems for semiconductor applications, and automated AFM metrology systems for High Bandwidth Memory production.

Revenue Model

Bruker sells scientific instruments on a transactional basis and generates recurring revenue from aftermarket services, software, and consumables tied to its installed instrument base. Some revenue flows through government contracts.

Customers & Markets

End markets include academic and government research laboratories, pharmaceutical and biotechnology companies, clinical microbiology and diagnostics, semiconductor and materials characterization, and AI chip manufacturing. Government agencies are named customers under formal contracts.

Geographic Exposure

Products are sold in the United States and international markets including the European Union. EU regulatory frameworks (Directive 98/79/EC and Regulation (EU) 2017/746) apply to certain diagnostic products. No specific revenue breakdown by geography is supported by the filing excerpts provided.

Financial Snapshot

Revenue
TTM
$3.459B
Gross Margin
TTM
45.65%
Net Income
TTM
-$22.70M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
155.24%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
$3.628B
Book Value
2026 Q1
2.503B
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
$22.20M

Stock Price

Loading...
Market Cap: $9.1427 Billion

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support